-
Sector Analysis
Six Nations (Rugby Championship), 2024 – Event Analysis
Six Nations Rugby Championship 2024 Event Analysis Report Overview The annual sponsorship revenue for the Six Nations Rugby Championship 2024 is estimated to be $26.33 million. The following are some of the key highlights of the Six Nations Rugby 2023 event analysis report: A Six Nations documentary released on Netflix before the tournament was aimed to increase the viewership for this year’s tournament. The opening game of the Six Nations brought in an audience of over 6 million for host...
-
Product Insights
Midway – CityCentre Six Office Tower – Texas
The Midway – CityCentre Six Office Tower – Texas involves the construction of a 19-story, 28,614m2 office tower at 903 Town and Country Blvd, Houston, Texas, the US. Equip yourself with the essential tools needed to make informed and profitable decisions with our Midway – CityCentre Six Office Tower – Texas report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends...
-
Consumer Insights
NewChina Apparel Consumer Insights – Who Shops, What do they Shop, How do they Shop and Why do they Shop
China Apparel Consumer Insights Report Overview Most Chinese consumers are optimistic about the country's economic outlook for the next six months, with nearly 50% of consumers expecting overall economic improvement and around the same percentage anticipating improvement in their finances. As a result, more Chinese consumers are planning to spend more on clothing & accessories, and footwear, especially among females, driven by their inclination toward following trends. There is a clear preference for online shopping among Chinese apparel shoppers, propelled...
-
Consumer Insights
United States (US) Apparel Consumer Insights – Who Shops, What do they Shop, How do they Shop and Why do they Shop
US Apparel Consumer Insights Report Overview More than 77% of US consumers bought apparel from physical stores in 2023. However, many consumers plan to cut back on their clothing and accessories spend over the next six months. Inflation is expected to ease in 2024, however, this has not reassured consumers about the outlook for the US economy in the next six months. The ‘US Apparel Consumer Insights Report’ provides detailed insights into consumer sentiment among apparel shoppers in the US....
-
Sector Analysis
NewUnited Kingdom (UK) Home Kitchen Furniture Market Trends, Analysis, Consumer Dynamics and Spending Habits
The UK: Home Category Data, The Consumer - Kitchen furniture 2024 report offers a comprehensive insight into consumer attitudes in the UK kitchen furniture market. The report focuses on six key subcategories: overall kitchen furniture, sinks & taps, kitchen cabinets, cupboard doors & accessories, worktops, and under counter lighting. Consumer data is based on our 2024 UK kitchen furniture survey, using a panel of 2,000 nationally representative consumers.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trastuzumab Deruxtecan in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trastuzumab Deruxtecan in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab Deruxtecan in Recurrent Glioblastoma Multiforme (GBM) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trastuzumab Deruxtecan in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trastuzumab Deruxtecan in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab Deruxtecan in Cervical Cancer Drug Details: Trastuzumab deruxtecan (Enhertu,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trastuzumab Deruxtecan in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trastuzumab Deruxtecan in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab Deruxtecan in Endometrial Cancer Drug Details: Trastuzumab deruxtecan (Enhertu,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trastuzumab Deruxtecan in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trastuzumab Deruxtecan in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab Deruxtecan in Epithelial Ovarian Cancer Drug Details: Trastuzumab...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trastuzumab Deruxtecan in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trastuzumab Deruxtecan in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab Deruxtecan in Esophageal Cancer Drug Details: Trastuzumab deruxtecan (Enhertu,...